|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02496 YZYBIO-B
Nominal 
3.300 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 33,143 | -10.875% | 66,858 | 107,813 | 0 | 0 |
| Cost of Sales | (7,887) | -73.281% | (56,123) | (22,744) | -- | -- |
| Gross Profit | 25,256 | 229.326% | 10,735 | 85,069 | -- | -- |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | (24,629) | (11,775) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (6,260) | -89.360% | (84,732) | (97,599) | (191,702) | (188,866) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (6,260) | -89.360% | (84,732) | (97,599) | (191,702) | (188,866) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,825 | -3.029% | 4,194 | 1,512 | 1,341 | 2,185 |
| Depreciation & Amortisation | 1,997 | -15.774% | 4,442 | 6,572 | 7,316 | 6,944 |
| Directors' Emoluments | -- | -- | 3,732 | 3,903 | 2,821 | 2,308 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -3.000 | -90.000% | -44.000 | -50.000 | -104.000 | -110.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.111) | (0.520) | (1.005) | (1.027) |
| NBV per share ($) | (0.302) | -- | (0.274) | 0.158 | 0.659 | -- |
| Remarks: | Real time quote last updated: 10/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -6,260 |
| %Change | -89.360% |
| EPS / (LPS) | RMB -0.030 |
| NBV Per Share (¥) | RMB -0.302 |